AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitapride-M 100/500 Tablet PR

Prescription Icon
Prescription Required

Marketer

Micro Labs Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitapride-M 100/500 Tablet PR

Diabetics with type 2 mellitus may benefit from the dual-action formula in Sitapride-M 100/500 Tablet PR, which effectively manages elevated blood glucose. This combination therapy helps mitigate severe diabetic complications, such as renal impairment and vision loss, and may decrease cardiovascular event risk (heart attack or stroke). Sitapride-M 100/500 Tablet PR can be used as monotherapy or in conjunction with other anti-diabetic treatments. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, blood sugar readings, and existing medications. Consuming this medication with meals minimizes gastrointestinal distress. For maximum therapeutic effect, adhere to a consistent daily dosing schedule; discontinuation should only occur under physician guidance. Maintaining the prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used concurrently with insulin or sulfonylureas; therefore, familiarity with hypoglycemia recognition and management is essential. This medication isn't universally suitable. Consult your physician before commencing treatment if you have a history of hepatic, renal, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical advice prior to use. Inform your doctor about all medications you are taking, as drug interactions may occur. Alcohol consumption should be minimized due to its potential to further reduce blood glucose levels. Your physician will monitor your renal function and blood glucose levels throughout your treatment.

Uses of Sitapride-M 100/500 Tablet PR

Managing type 2 diabetes

Major Benefits of Sitapride-M 100/500 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Sitapride-M 100/500 Tablet PR with meals.

Common Side effects of Sitapride-M 100/500 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapride-M 100/500 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Sitapride-M 100/500 Tablet PR with a meal.

How Sitapride-M 100/500 Tablet PR works:

Sitagliptin and metformin, combined as Sitapride-M 100/500 Tablet PR, work synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Sitapride-M 100/500 Tablet PR use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitapride-M 100/500 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitapride-M 100/500 tablets during breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitapride-M 100/500 Tablet PR, potentially requiring dosage modification. Physician consultation is recommended. Sitapride-M 100/500 Tablet PR is contraindicated in individuals with severe kidney disease. Regular kidney function assessments are advised during treatment.

LiverLiverUNSAFE

The use of Sitapride-M 100/500 tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Sitapride-M 100/500 Tablet PR :

Should you forget to take your Sitapride-M 100/500 Tablet PR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitapride-M 100/500 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Sitapride-M 100/500 Tablet PR

Sitapride-M 100/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitapride-M 100/500 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitapride-M 100/500 Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 100/500 Tablet PR components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitapride-M 100/500 Tablet PR is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 100/500 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the bloodstream. Also known as MALA (Metformin-associated lactic acidosis), this rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitapride-M 100/500 Tablet PR combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitapride-M 100/500 Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 100/500 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitapride-M 100/500 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitapride-M 100/500 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitapride-M 100/500 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitapride-M 100/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitapride-M 100/500 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 100/500 Tablet PR components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitapride-M 100/500 Tablet PR with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitapride-M 100/500 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitapride-M 100/500 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitapride-M 100/500 Table...
167
MRP 194
13% off